| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | UBA5 |
| Uniprot No | Q9GZZ9 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-404aa |
| 氨基酸序列 | MGSSHHHHHH SSGLVPRGSH MGSHMAESVE RLQQRVQELE RELAQERSLQ VPRSGDGGGG RVRIEKMSSE VVDSNPYSRL MALKRMGIVS DYEKIRTFAV AIVGVGGVGS VTAEMLTRCG IGKLLLFDYD KVELANMNRL FFQPHQAGLS KVQAAEHTLR NINPDVLFEV HNYNITTVEN FQHFMDRISN GGLEEGKPVD LVLSCVDNFE ARMTINTACN ELGQTWMESG VSENAVSGHI QLIIPGESAC FACAPPLVVA ANIDEKTLKR EGVCAASLPT TMGVVAGILV QNVLKFLLNF GTVSFYLGYN AMQDFFPTMS MKPNPQCDDR NCRKQQEEYK KKVAALPKQE VIQEEEEIIH EDNEWGIELV SEVSEEELKN FSGPVPDLPE GITVAYTIPK KQEDSVTELT VEDSGESLED LMAKMKNM |
| 预测分子量 | 47 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于UBA5重组蛋白的3篇参考文献及其简要摘要：
1. **文献名称**：*Structural insights into UBA5 activation and its role in ubiquitin-like protein conjugation*
**作者**：Smith J, et al.
**摘要**：通过X射线晶体学解析了UBA5重组蛋白的结构，揭示了其激活泛素样蛋白(如UFM1)的分子机制，并阐明了其与底物结合的关键结构域。
2. **文献名称**：*UBA5 mutations cause a new form of autosomal recessive developmental and epileptic encephalopathy*
**作者**：Li X, et al.
**摘要**：研究发现UBA5基因突变通过破坏重组蛋白的泛素化功能，导致神经发育异常和癫痫性脑病，揭示了UBA5在神经元发育中的关键作用。
3. **文献名称**：*Recombinant UBA5 protein exhibits E1-like enzymatic activity in vitro*
**作者**：Wang Y, et al.
**摘要**：通过体外实验验证了重组UBA5蛋白具有类似E1酶的活性，可激活UFM1并促进其与下游E2酶的结合，为研究泛素样修饰通路提供了实验基础。
4. **文献名称**：*UBA5 deficiency enhances cellular sensitivity to oxidative stress via impaired ubiquitin-like signaling*
**作者**：Chen L, et al.
**摘要**：利用重组UBA5蛋白模型，发现其缺失会削弱细胞对氧化应激的响应能力，表明UBA5通过调控泛素样信号通路参与细胞应激保护机制。
(注：以上文献为示例性内容，具体文献需通过学术数据库检索确认。)
**Background of UBA5 Recombinant Protein**
UBA5 (Ubiquitin-like modifier-activating enzyme 5) is a critical enzyme in the ubiquitin-activating enzyme (UAE) family, responsible for initiating the post-translational modification of ubiquitin-like proteins (UBLs). It specifically activates the ubiquitin-fold modifier 1 (UFM1) through a two-step ATP-dependent process, forming a thioester bond between its catalytic cysteine and UFM1. This UFM1 conjugation system plays vital roles in endoplasmic reticulum (ER)-associated processes, including ER-phagy, ribosome homeostasis, and cellular stress responses. Dysregulation of UBA5 has been linked to neurological disorders, such as developmental epileptic encephalopathy, and cancer progression.
Recombinant UBA5 protein is engineered using heterologous expression systems (e.g., *E. coli*, mammalian cells) to produce purified, functional UBA5 for *in vitro* studies. Its recombinant form retains enzymatic activity, enabling researchers to dissect UBA5-UFM1 signaling mechanisms, screen for modulators, or model pathogenic mutations. Structural studies using recombinant UBA5 have revealed its unique N-terminal ubiquitin-activating domain and C-terminal region, which differentiates it from other UAE members.
Research applications include investigating UBA5’s role in autophagy, tumor suppression, and neurodevelopment. Additionally, recombinant UBA5 aids in developing therapeutic strategies targeting UFMylation pathways implicated in diseases. Its production and characterization are essential for advancing understanding of ubiquitin-like protein systems and their pathological intersections.
×
